Research led by Jeff Gidday, PhD, Professor of Ophthalmology, Biochemistry, Neuroscience, and Physiology at LSU Health New Orleans School of Medicine, reports what is believed to be the first study in a mammalian model documenting the reprogramming of …
Author: The Medical News
Fight for Sight partners with Diabetes UK to investigate link between eye disease and COVID-19
Eye research charity Fight for Sight is partnering with Diabetes UK to investigate if people with the eye disease diabetic retinopathy are at greater risk of developing complications from Covid-19, in a study that hopes to save lives.
Therapeutic derived from turmeric shows promise in treating canine ocular condition
Researchers at Texas A&M University have produced a therapeutic derived from turmeric, a spice long-praised for its natural anti-inflammatory properties, that shows promise in decreasing ocular inflammation in dogs suffering from uveitis, an inflammati…
Survey shows pandemic will limit access to pediatric eye care
Pediatric ophthalmologists are a rarity in medicine. There are only about a thousand of them to serve America’s 75 million children. And as other physicians fled private practice for hospitals or have been gobbled up by private equity firms, most pedia…
Surgeons use patients’ own stem cells to rebuild damaged corneas
Surgeons at Massachusetts Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as “cultivated autologous limbal…
Scientists explain why SARS-CoV-2 targets multiple organs
Now, a team of researchers at LSU Health New Orleans’ Neuroscience Center of Excellence and School of Medicine has explained the gateway receptor for SARS-CoV-2 and how it leads to the emergence of many complications as it targets many parts of the bod…
Younger cycad seeds pose greater risk for toxicity, study reveals
University of Guam research has revealed that younger cycad seeds pose a greater risk for toxicity when consumed than more mature seeds, bringing the scientific community one step closer to understanding the origins of a neurodegenerative disease preva…
Study may help explain the symptoms and organs involved with SARS-CoV-2 infection
A study of a gateway receptor for SARS-CoV-2 led by Walter Lukiw, PhD, Professor of Neuroscience, Neurology and Ophthalmology at LSU Health New Orleans’ Neuroscience Center of Excellence and School of Medicine, may help explain the wide variety of symp…
Nanoparticle carriers expand the effectiveness of gene therapies for human eye diseases
NIBIB-funded researchers have created nanoparticles for successful gene therapy of a mouse model of macular degeneration.
A software-based on AI helps assess the progression of geographic atrophy
A software-based on artificial intelligence (AI), which was developed by researchers at the Eye Clinic of the University Hospital Bonn, Stanford University and University of Utah, enables the precise assessment of the progression of geographic atrophy …
Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten disease
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.
OU Health Sciences Center awarded five-year grant for suicide prevention
The University of Oklahoma Health Sciences Center has been awarded a five-year, $38 million grant to lead and expand a national program dedicated to suicide prevention.
Researchers shed new light on epigenetic changes associated with ADNP syndrome
A study led by the Seaver Autism Center for Research and Treatment at Mount Sinai found that two different blood epigenetic signatures associated with ADNP syndrome (also known as Helsmoortel-Van Der Aa syndrome) have only a modest correlation with cli…
Study finds predictive factors for laser treatment success in patients with glaucoma
More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness.
UOttawa’s Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists
The Faculty of Medicine has awarded 58 clinical research chairs to top clinician-scientists in a five-year, $40 million investment to drive clinical research excellence and enhance health and patient care.
Researchers discover neural progenitor cells in the optic nerve
Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain.
OU physician receives $1.6 million NIH grant for knee osteoarthritis research
By the time they turn 65, at least half of people suffer from osteoarthritis, a condition that impairs quality of life and cannot be slowed by medication.
Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies
Harvard University’s Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therap…
Researchers win grant to study why COVID-19 patients lose their sense of smell
Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.
Cutting-edge surgery enables patients with facial paralysis to close their eyes
Surgeons at UT Southwestern have developed and analyzed the benefits of a cutting-edge technique that provides patients with facial paralysis the ability to close their eyes.